High Flow Oxygen Therapy

2

Review clinical trials related to High Flow Oxygen Therapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

High Flow Tracheal Oxygen for Weaning of Tracheostomized Patients

In this pilot randomized controlled trial (RCT), the investigators aim to explore the feasibility of conducting a powered RCT that examines the efficacy and safety of high flow tracheal oxygen (HFTO) in weaning critically ill tracheostomy patients from mechanical ventilation. Objective of the study 1. To assess the feasibility of conducting a larger RCT as primary objective. 2. To explore the effect of using HFTO in mechanically ventilated tracheostomized critically ill patients on ventilator-free days (VFD) compared to standard of care method using tracheal mask (TM) as secondary objective.

Participants needed: 88
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: King Faisal Specialist Hospital & Research CenterUpdated: Jun 2, 2026Locations: 1
Eligibility criteria

Adults ≥ 18 years of age [+3]

Planned tracheostomy post head and neck surgery with ICU stay less than 48 hours [+4]

Status: Recruiting

Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy

Several factors can influence oxygenation monitoring and respiratory support through oxygen therapy: the type of oximeter used, skin pigmentation, and the oxygenation target. It is essential to have an accurate measurement of SpO2 in order to optimize the flow of oxygen or FiO2 administered to patients. The question arises as to the impact of these confounding factors on the FiO2 set during high-flow nasal oxygen therapy. The aim of the study is to evaluate the impact of the oxygenation target and the oximeter used on FiO2 in patients receiving high-flow nasal oxygen therapy.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Laval UniversityUpdated: Mar 9, 2026Locations: 1
Eligibility criteria

≥ 18 years of age [+3]

No SpO2 signal with oximeter in use [+4]